logo

Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder.

This page provides detailed information about this publication. Please click on any text which is underlined to find more information.


Authors
Jeffrey R. Bishop, Fedra Najjar, Leah H. Rubin, Stephen J. Guter, Thomas Owley, Matthw W. Mosconi, Suma Jacob, Edwin H. Cook
Title
Escitalopram pharmacogenetics: CYP2C19 relationships with dosing and clinical outcomes in autism spectrum disorder.
Journal
Pharmacogenetics and Genomics
Year
2015
Month
November
Volume
25
Issue
11
Page(s)
pp. 548-554.
Abstract Link
Read Abstract (New Window)
Publication Format
Journal Article
Efficacy Study/Review
Yes
Scientific Validity
Peer-Reviewed, Open Trial
Keywords
Adolescent / Secondary School Age, Adult, Antidepressants, Asperger Syndrome, Autism, Autistic Disorder, Child/Children, Escitalopram, Intervention, Irritability, Medication, Pervasive Developmental Disorder (Not Otherwise Specified), Pre-School / Toddlers, Primary / Elementary School Age, Selective Serotonin Reuptake Inhibitors

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.


Related Pages


Publications | Publications Database | Search Publications